Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells.
Studies of the reaction of antibody A2B5 and tetanus toxin with pancreatic islet cells, islet cell tumors, and other human amine precursor uptake and decarboxylation (APUD) tumors are described. By indirect immunofluorescence, antibody A2B5 and tetanus toxin were shown to specifically bind to the plasma membrane of human, rat, chicken, and mouse islet cells. The binding of antibody A2B5 to the cell surface of living islet cells has allowed isolation of these cells from a suspension of pancreatic cells by using a fluorescence-activated cell sorter. In studies designed to determine whether tetanus toxin and antibody A2B5 bound to the same surface antigen, A2B5 and tetanus toxin did not compete for binding to normal islet cells, a human islet cell tumor, or a rat islet cell tumor. In addition to binding to islet cell tumors, antibody A2B5 reacts with frozen sections, isolated cells, and cell lines of neural, neural crest, and APUD origin.
D000818:Animals; D000911:Antibodies, Monoclonal; D000954:Antigens, Surface / Q000032:analysis*; D002645:Chickens; D005732:Gangliosides / Q000276:immunology*; D006801:Humans; D007515:Islets of Langerhans / Q000196:embryology / Q000276:immunology*; D008565:Membrane Proteins; D009474:Neurons / Q000276:immunology; D051381:Rats; D011950:Receptors, Cholinergic / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D005732:Gangliosides; D008565:Membrane Proteins; D011950:Receptors, Cholinergic; C028728:tetanus toxin receptor